title: 14-3-3ε marks the amyloid-stimulated microglia long-term activation.
abstract: Microglia-mediated inflammation in the central nervous system is a hallmark of the pathogenesis of several neurodegenerative diseases including Alzheimer's disease. Microglial cells activation follows the deposition of amyloid β fibrils and it is generally considered a triggering factor in the early steps of the onset of Alzheimer's disease. Although the initial engagement of microglia seems to play a neuroprotective role, many lines of evidence indicate that a persistent activation with the production of proinflammatory molecules contributes to dismantle neuronal activity and to induce neuronal loss occurring in neurodegenerative diseases. To date, limited proteomic data are available on activated microglial cells in response to extracellular amyloidogenic peptides. In this study, murine microglial cells have been employed to investigate the effects of amyloid β peptides in triggering microglial activation. The response was monitored at the proteome level through a two-dimensional gel electrophoresis-based approach. Results show only a limited number of differentially expressed proteins, among these a more acidic species of the cytosolic actin, and the 14-3-3ε protein, found significantly upregulated in Aβ-activated cells. 14-3-3ε belongs to a regulatory protein family involved in important cellular processes, including those leading to neurodegenerative diseases, and thus its increased expression suggests a role of this protein in tuning microglia activation.
authors: Dipartimento di Scienze Biochimiche, Sapienza, University of Rome, Rome, Italy.
authors: Laura
authors: L
authors: Di Francesco
authors: Virginia
authors: V
authors: Correani
authors: Cinzia
authors: C
authors: Fabrizi
authors: Lorenzo
authors: L
authors: Fumagalli
authors: Michele
authors: M
authors: Mazzanti
authors: Bruno
authors: B
authors: Maras
authors: M Eugenia
authors: ME
authors: Schininà
mesh_terms: D048948:14-3-3 Proteins / Q000235:genetics / Q000378:metabolism*; D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology; D016229:Amyloid beta-Peptides; D058227:Amyloidogenic Proteins; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D002461:Cell Line, Transformed; D007249:Inflammation / Q000139:chemically induced / Q000378:metabolism*; D051379:Mice; D017628:Microglia / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D020543:Proteome / Q000235:genetics / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D048948:14-3-3 Proteins; D016229:Amyloid beta-Peptides; D058227:Amyloidogenic Proteins; D015415:Biomarkers; D020543:Proteome